David Nannemann

Получаване на мой собствен потребителски профил

Позовавания

	Всички	От 2019
Позовавания	832	468
h-индекс	12	12
i10-индекс	13	12

100

2010201120122013201420152016201720182019202020212022202320243 6 9 21 46 59 78 66 70 72 74 96 96 76 54

Публичен достъп

Преглед на всички

14 статии

0 статии

налични

неналични

Въз основа на изисквания при финансирането

Съавтори

Jens MeilerVanderbilt University & University LeipzigПотвърден имейл адрес: meilerlab.org
Brian O. BachmannAssociate Professor of Chemistry, Vanderbilt UniversityПотвърден имейл адрес: vanderbilt.edu
Vanita SoodEMD Serono Research Institute & Development InstituteПотвърден имейл адрес: emdserono.com
Tina IversonVanderbilt UniversityПотвърден имейл адрес: vanderbilt.edu
Sam DeLucaCyrus BiotechnologyПотвърден имейл адрес: cyrusbio.com
Jonathan H. SheehanAssociate Professor, Washington Univ. School of Medicine in St. LouisПотвърден имейл адрес: wustl.edu
James CroweVanderbilt University Medical CenterПотвърден имейл адрес: vanderbilt.edu
Gopal SapparapuUCLAПотвърден имейл адрес: UCLA.edu
Sheng LiUniversity of California, San DiegoПотвърден имейл адрес: ucsd.edu
Andrea SinzProfessorin für Pharmazeutische Chemie, Martin-Luther-Universität Halle-WittenbergПотвърден имейл адрес: pharmazie.uni-halle.de
Gordon LemmonUniversity of UtahПотвърден имейл адрес: utah.edu
Elizabeth Dong NguyenUniversity of WashingtonПотвърден имейл адрес: uw.edu
Steven CombsJohnson and JohnsonПотвърден имейл адрес: its.jnj.com
Brett KronckeVanderbilt University Medical CenterПотвърден имейл адрес: vumc.org
Wade Van HornThe Biodesign Center for Personalized Diagnostics, The School of Molecular Sciences, Arizona StateПотвърден имейл адрес: asu.edu
Charles R. SandersProfessor of Biochemistry, Vanderbilt UniversityПотвърден имейл адрес: vanderbilt.edu
Chrystal StarbirdAssistant Professor at University of North Carolina at Chapel HillПотвърден имейл адрес: email.unc.edu
Philip LösslScientific Director, Absea BiotechnologyПотвърден имейл адрес: absea.bio
Frank ZauckeDepartment of Orthopaedics (Friedrichsheim), University Hospital Frankfurt, Goethe UniversityПотвърден имейл адрес: kgu.de
gary sawersInstitute for Microbiology, Martin-Luther University Halle-WittenbergПотвърден имейл адрес: mikrobiologie.uni-halle.de

Следене

David Nannemann

Rosetta Design Group

Потвърден имейл адрес: rosettadesigngroup.com

directed evolution docking modeling protein design


Заглавие Сортиране по цитати Сортиране по година Сортиране по заглавие	Позовавания Позовавания	Година
Small-molecule ligand docking into comparative models with Rosetta SA Combs, SL DeLuca, SH DeLuca, GH Lemmon, DP Nannemann, ... Nature protocols 8 (7), 1277-1298, 2013	206	2013
Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore MS Aiyegbo, G Sapparapu, BW Spiller, IM Eli, DR Williams, R Kim, ... PloS one 8 (5), e61101, 2013	94	2013
Assessing directed evolution methods for the generation of biosynthetic enzymes with potential in drug biosynthesis DP Nannemann, WR Birmingham, RA Scism, BO Bachmann Future medicinal chemistry 3 (7), 809-819, 2011	77	2011
Bioretrosynthetic construction of a didanosine biosynthetic pathway WR Birmingham, CA Starbird, TD Panosian, DP Nannemann, TM Iverson, ... Nature chemical biology 10 (5), 392-399, 2014	68	2014
Analysis of nidogen-1/laminin γ1 interaction by cross-linking, mass spectrometry, and computational modeling reveals multiple binding modes P Lössl, K Kölbel, D Tänzler, D Nannemann, CH Ihling, MV Keller, ... PLoS One 9 (11), e112886, 2014	62	2014
Pyruvate formate-lyase interacts directly with the formate channel FocA to regulate formate translocation C Doberenz, M Zorn, D Falke, D Nannemann, D Hunger, L Beyer, ... Journal of molecular biology 426 (15), 2827-2839, 2014	54	2014
Structural basis for KCNE3 modulation of potassium recycling in epithelia BM Kroncke, WD Van Horn, J Smith, CB Kang, RC Welch, Y Song, ... Science Advances 2 (9), e1501228, 2016	51	2016
Bacillus cereus phosphopentomutase is an alkaline phosphatase family member that exhibits an altered entry point into the catalytic cycle TD Panosian, DP Nannemann, GR Watkins, VV Phelan, WH McDonald, ... Journal of Biological Chemistry 286 (10), 8043-8054, 2011	41	2011
Design and directed evolution of a dideoxy purine nucleoside phosphorylase DP Nannemann, KW Kaufmann, J Meiler, BO Bachmann Protein Engineering, Design & Selection 23 (8), 607-616, 2010	41	2010
Identification and characterization of M6903, an antagonistic anti–TIM-3 monoclonal antibody D Zhang, F Jiang, R Zaynagetdinov, H Huang, VD Sood, H Wang, X Zhao, ... Oncoimmunology 9 (1), 1744921, 2020	36	2020
Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies B Grinshpun, N Thorsteinson, JNS Pereira, F Rippmann, D Nannemann, ... MAbs 13 (1), 1932230, 2021	35	2021
Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses NJ Thornburg, DP Nannemann, DL Blum, JA Belser, TM Tumpey, ... The Journal of clinical investigation 123 (10), 4405-4409, 2013	35	2013
Molecular Differences between a Mutase and a Phosphatase: Investigations of the Activation Step in Bacillus cereus Phosphopentomutase TM Iverson, TD Panosian, WR Birmingham, DP Nannemann, ... Biochemistry 51 (9), 1964-1975, 2012	11	2012
In silico analysis and experimental verification of OSR1 kinase–Peptide interaction TM Austin, DP Nannemann, SL Deluca, J Meiler, E Delpire Journal of structural biology 187 (1), 58-65, 2014	9	2014
Crystallization and preliminary X-ray analysis of a phosphopentomutase from Bacillus cereus TD Panosian, DP Nannemann, BO Bachmann, TM Iverson Acta Crystallographica Section F: Structural Biology and Crystallization …, 2010	7	2010
Guanylate Cyclase-Activating Protein-2 Undergoes Structural Changes upon Binding to Detergent Micelles and Bicelles A Margetić, D Nannemann, J Meiler, D Huster, S Theisgen Biochimica et Biophysica Acta (BBA)-Biomembranes 1838 (11), 2767-2777, 2014	3	2014
Anti-tim-3 antibodies D Zhang, X Zhao, Q An, D Nannemann, R Zaynagetdinov, V Sood, ... US Patent App. 17/245,474, 2022	1	2022
Anti-tim-3 antibodies D Zhang, X Zhao, AN Qi, D NANNEMANN, R ZAYNAGEDINOV, S Vanita, ...	1	2020
Monoclonal antibody directed to FGFR1 C Iffland, C Esdar, X Zhao, Q An, J Yeh, G Hao, L Toleikis, V Sood, ... US Patent 11,597,771, 2023		2023
Anti-TIGIT Antibodies and Uses Thereof D Zhang, C Kelton, L Li, D Nannemann, Q An, C Iffland, X Zhao, J Yeh US Patent App. 17/774,685, 2022		2022

Системата не може да изпълни операцията сега. Опитайте отново по-късно.

Статии 1–20

Позовавания годишно

Дублирани описания

Обединени библиографски описания

Добавяне на съавториСъавтори

Следене

Позовавания

Съавтори